Please use a PC Browser to access Register-Tadawul
Get It
BRIEF-Insight Molecular Diagnostics Completes Key Milestones Advancing Graftassuredx Toward FDA Submission
Insight Molecular Diagnostics Inc. IMDX | 5.35 5.35 | -0.93% 0.00% Post |
March 3 (Reuters) - Insight Molecular Diagnostics Inc IMDX.O:
INSIGHT MOLECULAR DIAGNOSTICS COMPLETES KEY MILESTONES ADVANCING GRAFTASSUREDX TOWARD FDA SUBMISSION
Source text: ID:nGNX2NRcnn
Further company coverage: IMDX.O
